More than one million people are living with Multiple Sclerosis, a chronic and unpredictable disease of the central nervous system (CNS). MS is thought to be an immune-mediated disorder, in which the immune system attacks healthy tissue in the CNS.
The good news for those living with MS through the COVID-19 pandemic is that MS does not pose more risk for COVID-19 than the general population, and MS patients can safely receive COVID-19 therapies if they do become ill.
And, there's even more good news. Mavenclad is a new treatment option that allows patients to skip infusions and trips to the infusion center. Mavenclad is an FDA approved pill that can help with typical MS symptoms.
Learn more and find safety information and more here.
